Parkinson's disease and vision

Basal Ganglia

Volumn 3, Issue 3, 2013, Pages 159-163

  Sauerbier, Anna ^a,b   Ray Chaudhuri, Kallol ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Non motor symptoms; Parkinson's disease

Indexed keywords

AMANTADINE; ARTIFICIAL TEAR; BOTULINUM TOXIN A; BOTULINUM TOXIN B; DOPAMINE; LEVODOPA;

BLEPHARITIS; BLEPHAROSPASM; BLURRED VISION; COLOR DISCRIMINATION; CONTRAST SENSITIVITY; CORNEA EDEMA; DEPTH PERCEPTION; DIPLOPIA; DRY EYE; EYE DISCOMFORT; EYE PAIN; HALLUCINATION; HUMAN; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; REM SLEEP; REVIEW; SACCADIC EYE MOVEMENT; SPECTACLES; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD DEFECT; XEROPHTHALMIA;

EID: 84888876669     PISSN: 22105336     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.baga.2013.05.002     Document Type: Review

References (67)

1. Witjas T., Kaphan E., Azulay J.P., Blin O., Ceccaldi M., Pouget J., et al. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002, 59:408-413.
2. Archibald N.K., Clarke M.P., Mosimann U.P., Burn D.J. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Movement Disorders 2011, 26:2387-2395.
3. Almer Z., Klein K.S., Marsh L., Gerstenhaber M., Repka M.X. Ocular motor and sensory function in Parkinson disease. Ophthalmology 2012, 119:178-182.
4. Diederich N.J., Pieri V., Hipp G., Rufra O., Blyth S., Vaillant M. Discriminative power of different nonmotor signs in early Parkinson's disease. A case-control study. Movement Disorders 2010, 25:882-887.
5. Bodis-Wollner I. Retinopathy in Parkinson disease. Journal of Neural Transmission 2009, 116:1493-1501.
6. Davidsdottir S., Cronin-Golomb A., Lees A. Visual and spatial symptoms in Parkinson's disease. Vision Research 2005, 45:1285-1296.
7. Kesler A., Korczyn A.D. Visual disturbances in Parkinson's disease. Practical Neurology 2006, 6:28-33.
8. Chaudhuri K.R., Martinez-Martin P., Schapira A.H., Stocchi F., Sethi K., Odin P., et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Movement Disorders 2006, 21:916-923.
9. Romenets S.R., Wolfson C., Galatas C., Pelletier A., Altman R., Wadup L., et al. Validation of the non-motor symptoms questionnaire (NMS-Quest). Parkinsonism and Related Disorders 2012, 18:54-58.
10. Chaudhuri K.R., Prieto-Jurcynska C., Naidu Y., Mitra T., Frades-Payo B., Tluk S., et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Movement Disorders 2010, 25:704-709.
11. Yu B., Xiao Z.Y., Li J.Z., Yuan J., Liu Y.M. Study of an integrated non-motor symptoms questionnaire for Parkinson's disease. Chinese Medical Journal (England) 2010, 123:1436-1440.
12. Amick M.M., Cronin-Golomb A., Gilmore G.C. Visual processing of rapidly presented stimuli is normalized in Parkinson's disease when proximal stimulus strength is enhanced. Vision Research 2003, 43:2827-2835.
13. Bodis-Wollner I., Marx M.S., Mitra S., Bobak P., Mylin L., Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987, 110:1675-1698.
14. Pieri V., Diederich N.J., Raman R., Goetz C.G. Decreased color discrimination and contrast sensitivity in Parkinson's disease. Journal of Neurological Sciences 2000, 172:7-11.
15. Diederich N.J., Goetz C.G., Raman R., Pappert E.J., Leurgans S., Piery V. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clinical Neuropharmacology 1998, 21:289-295.
16. Cronin-Golomb A., Braun A.E. Visuospatial dysfunction and problem solving in Parkinson's disease. Neuropsychology 1997, 11:44-52.
17. Crevits L., De Ridder K. Disturbed striatoprefrontal mediated visual behaviour in moderate to severe parkinsonian patients. Journal of Neurology Neurosurgery and Psychiatry 1997, 63:296-299.
18. Shibasaki H., Tsuji S., Kuroiwa Y. Oculomotor abnormalities in Parkinson's disease. Archives of Neurology 1979, 36:360-364.
19. White O.B., Saint-Cyr J.A., Tomlinson R.D., Sharpe J.A. Ocular motor deficits in Parkinson's disease, II. Control of the saccadic and smooth pursuit systems. Brain 1983, 106:571-587.
20. Fenelon G., Mahieux F., Huon R., Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000, 123:733-745.
21. Hindle S.J., Elliott C.J. Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease. Autophagy 2013, 25:9.
22. Kertelge L., Brüggemann N., Schmidt A., Tadic V., Wisse C., Dankert S., et al. Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease. Movement Disorders 2010, 25:2665-2669.
23. Muresan Z., Besharse J.C. D2-like dopamine receptors in amphibian retina: localization with fluorescent ligands. Journal of Comparative Neurology 1993, 331:149-160.
24. Krizaj D., Gabriel R., Owen W.G., Witkovsky P. Dopamine d2 receptor-mediated modulation of rod-cone coupling in the xenopus retina. Journal of Comparative Neurology 1998, 398:529-538.
25. Akopian A., Witkovsky P. D2 dopamine receptor-mediated inhibition of a hyperpolarization-activated current in rod photoreceptors. Journal of Neurophysiology 1996, 76:1828-1835.
26. Herrmann R., Heflin S.J., Hammond T., Lee B., Wang J., Gainetdinov R.R., et al. Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. Neuron 2011, 72:101-110.
27. Harnois C., Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Investigative Ophthalmology and Visual Science 1990, 31:2473-2475.
28. Nguyen-Legros J. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surgical and Radiological Anatomy: SRA 1988, 10:137-144.
29. Nguyen-Legros JH.C., DiPaolo T., Simon A. The retinal dopamine system in Parkinson's disease. Clinical Vision Sciences 1993, 8:1-12.
30. Diederich N.J., Goetz C.G., Stebbins G.T. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Movement Disorders 2005, 20:130-140.
31. Haug B.A., Trenkwalder C., Arden G.B., Oertel W.H., Paulus W. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease. Movement Disorders 1994, 9:563-570.
32. Archibald N.K., Clarke M.P., Mosimann U.P., Burn D.J. The retina in Parkinson's disease. Brain 2009, 132:1128-1145.
33. Oh Y.S., Kim J.S., Chung S.W., Song I.U., Kim Y.D., Kim Y.I., et al. Color vision in Parkinson's disease and essential tremor. European Journal of Neurology 2011, 18:577-583.
34. Schenck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996, 46:388-393.
35. Iranzo A., Molinuevo J.L., Santamaría J., Serradell M., Martí M.J., Valldeoriola F., et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurology 2006, 5:572-577.
36. Postuma R.B., Gagnon J.F., Montplaisir J.Y. REM sleep behavior disorder and prodromal neurodegeneration - where are we headed?. Tremor and Other Hyperkinetic Movements (New York) 2013, 3.
37. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurology 2009, 8:464-474.
38. Owen A.M., Beksinska M., James M., Leigh P.N., Summers B.A., Marsden C.D., et al. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia 1993, 31:627-644.
39. Owen A.M., James M., Leigh P.N., Summers B.A., Marsden C.D., Quinn N.P., et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992, 115:1727-1751.
40. Bohnen N.I., Minoshima S., Giordani B., Frey K.A., Kuhl D.E. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology 1999, 52:541-546.
41. Wang L., Kuroiwa Y., Kamitani T. Visual event-related potential changes at two different tasks in non demented Parkinson's disease. Journal of the Neurological Sciences 1999, 164:139-147.
42. Mosimann U.P., Rowan E.N., Partington C.E., Collerton D., Littlewood E., ÓBrien J.T., et al. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies. American Journal of Geriatric Psychiatry 2006, 14:153-160.
43. Deuschl G., Goddemeier C. Spontaneous and reflex activity of facial muscles in dystonia, Parkinson's disease, and in normal subjects. Journal of neurology, neurosurgery and psychiatry 1998, 64:320-324.
44. Agostino R., Bologna M., Dinapoli L., Gregori B., Fabbrini G., Accornero N., et al. Voluntary, spontaneous, and reflex blinking in Parkinson's disease. Movement Disorders 2008, 23:669-675.
45. Biousse V., Skibell B.C., Watts R.L., Loupe D.N., Drews-Botsch C., Newman N.J. Ophthalmologic features of Parkinson's disease. Neurology 2004, 62:177-180.
46. Waterston J.A., Barnes G.R., Grealy M.A., Collins S. Abnormalities of smooth eye and head movement control in Parkinson's disease. Annals of Neurology 1996, 39:749-760.
47. Pinkhardt E.H., Jügens R., Lulé D., Heimrath J., Ludolph A.C., Becker W., et al. Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms. BMC Neurology 2012, 12:5.
48. Rieger J.W., Kim A., Argyelan M., Farber M., Glazman S., Liebeskind M., et al. Cortical functional anatomy of voluntary saccades in Parkinson disease. Clinical EEG and Neuroscience 2008, 39:169-174.
49. Bye L., Chaudhuri K.R. Diplopia in Parkinson's disease: a clinical and optometric study. Movement Disorders 2007, 22:S182-S183.
50. Armstrong R.A. Visual symptoms in Parkinson's disease. Parkinsons Disease 2011, 2011:908306.
51. Lepore F.E. Parkinson's disease and diplopia. Neuro-Ophthalmology 2006, 30:37-40.
52. Nebe A., Ebersbach G. Selective diplopia in Parkinson's disease: a special subtype of visual hallucination?. Movement Disorders 2007, 22:1175-1178.
53. Huang F.C., Tseng S.H., Shih M.H., Chen F.K. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology 2002, 109:1934-1940.
54. Kusbeci T., Kusbeci O.Y., Aktepe O.C., Yavas G., Ermis S.S. Conjunctival flora in patients with Parkinson's disease. Current Eye Research 2009, 34:251-256.
55. Williams D.R., Lees A.J. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurology 2005, 4:605-610.
56. Ibarretxe-Bilbao N., Junque C., Marti M.J., Tolosa E. Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies. Journal of Neurological Sciences 2011, 310:79-81.
57. Pacchetti C., Manni R., Zangaglia R., Mancini F., Marchioni E., Tassorelli C., et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Movement Disorders 2005, 20:1439-1448.
58. Manni R., Terzaghi M., Ratti P.L., Repetto A., Zangaglia R., Pacchetti C. Hallucinations and REM sleep behaviour disorder in Parkinson's disease: dream imagery intrusions and other hypotheses. Consciousness and Cognition 2011, 20:1021-1026.
59. Shine J.M., Halliday G.H., Carlos M., Naismith S.L., Lewis S.J. Investigating visual misperceptions in Parkinson's disease: a novel behavioral paradigm. Movement Disorders 2012, 27:500-505.
60. Marino S., Lanzafame P., Sessa E., Bramanti A., Bramanti P. The effect of L-Dopa administration on pursuit ocular movements in suspected Parkinson's disease. Neurological Sciences 2010, 31:381-385.
61. Kubo S., Iwatake A., Ebihara N., Murakami A., Hattori N. Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature. Parkinsonism and Related Disorders 2008, 14:166-169.
62. Ghaffariyeh A., Honarpisheh N. Amantadine-associated corneal edema. Parkinsonism and Related Disorders 2010, 16:427.
63. Jankovic J., Comella C., Hanschmann A., Grafe S. Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm - a randomized trial. Movement Disorders 2011, 26:1521-1528.
64. ®) injections in blepharospasm. Journal of Neural Transmission 2013.
65. Hallett M., Albanese A., Dressler D., Segal K.R., Simpson D.M., Truong D., et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon 2012.
66. Yenice O., Onal S., Midi I., Ozcan E., Temel A., I-Gunal D. Visual field analysis in patients with Parkinson's disease. Parkinsonism and Related Disorders 2008, 14:193-198.
67. Bye L., Vamadevan P., Chaudhuri K.R. Ophthalmological aspects of Parkinson's disease. Non motor symptoms of Parkinson's disease 2009, 297-307. Oxford University Press, Oxford, UK, Chapter 24. K.R. Chaudhuri, E. Tolosa, A. Schapira, W. Poewe (Eds.).